Impaired host resistance to Salmonella during helminth co-infection is restored by anthelmintic treatment prior to bacterial challenge

Autor: Dongju Shin, Brandon E. Moeller, Katherine M Lawrence, Lisa A. Reynolds, Mia H E Kennedy, Courtney M. Gauthier, Kate M. E. Conway, Dominique M. Gatti, Rachael D. FitzPatrick, Tara P. Brosschot
Rok vydání: 2021
Předmět:
Male
Bacterial Diseases
0301 basic medicine
Salmonella
Salmonellosis
RC955-962
Helminthiasis
Salmonella infection
Pathology and Laboratory Medicine
medicine.disease_cause
Mice
fluids and secretions
Medical Conditions
0302 clinical medicine
Arctic medicine. Tropical medicine
Medicine and Health Sciences
Colonization
Anthelmintic
Intestinal Diseases
Parasitic

Helminthic therapy
Disease Resistance
Mice
Inbred BALB C

Nematospiroides dubius
biology
Coinfection
Eukaryota
Bacterial Pathogens
3. Good health
Intestines
Infectious Diseases
medicine.anatomical_structure
Medical Microbiology
Helminth Infections
Salmonella Infections
Salmonella Typhimurium
Small Intestine
Female
Immunotherapy
Public aspects of medicine
RA1-1270
Pathogens
Anatomy
Research Article
medicine.drug
Immunology
030231 tropical medicine
Microbiology
03 medical and health sciences
Enterobacteriaceae
Helminths
parasitic diseases
Parasitic Diseases
medicine
Animals
Microbial Pathogens
Bacteria
Organisms
Public Health
Environmental and Occupational Health

Biology and Life Sciences
Salmonella typhi
biology.organism_classification
medicine.disease
Invertebrates
Small intestine
Gastrointestinal Microbiome
Helminthic Therapy
Mice
Inbred C57BL

Gastrointestinal Tract
Disease Models
Animal

030104 developmental biology
Clinical Immunology
Heligmosomoides polygyrus
Clinical Medicine
Zoology
Digestive System
Zdroj: PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 15, Iss 1, p e0009052 (2021)
ISSN: 1935-2735
Popis: Intestinal helminth infection can impair host resistance to co-infection with enteric bacterial pathogens. However, it is not known whether helminth drug-clearance can restore host resistance to bacterial infection. Using a mouse helminth-Salmonella co-infection system, we show that anthelmintic treatment prior to Salmonella challenge is sufficient to restore host resistance to Salmonella. The presence of the small intestine-dwelling helminth Heligmosomoides polygyrus at the point of Salmonella infection supports the initial establishment of Salmonella in the small intestinal lumen. Interestingly, if helminth drug-clearance is delayed until Salmonella has already established in the small intestinal lumen, anthelmintic treatment does not result in complete clearance of Salmonella. This suggests that while the presence of helminths supports initial Salmonella colonization, helminths are dispensable for Salmonella persistence in the host small intestine. These data contribute to the mechanistic understanding of how an ongoing or prior helminth infection can affect pathogenic bacterial colonization and persistence in the mammalian intestine.
Author summary In regions where helminth infection is common and sanitation standards are poor, people are at a high risk of exposure to bacterial pathogens. Previous work in animal models has shown that helminth infection can impair host resistance to bacterial infection. The current treatment for helminth infection is the administration of helminth-clearing drugs, yet it is not known whether drug clearance of helminths restores helminth-impaired host resistance to bacterial infection. In this report we use a mouse helminth-Salmonella co-infection model system, where we find that the presence of small intestinal helminths at the point of Salmonella infection aids the establishment of Salmonella in the small intestinal lumen. We show that helminth drug clearance prior to Salmonella infection is sufficient to restore host resistance to Salmonella. However, if helminth drug clearance is delayed until after Salmonella had already established in the small intestinal lumen, helminth elimination does not result in complete clearance of Salmonella from this site. Our work suggests that helminth drug clearance may be beneficial in reducing susceptibility to subsequent intestinal bacterial infections, but that helminth drug clearance after co-infection may not result in clearance of bacterial populations that have firmly established in the intestinal lumen.
Databáze: OpenAIRE